• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静电建模可预测正痘病毒补体控制蛋白的活性。

Electrostatic modeling predicts the activities of orthopoxvirus complement control proteins.

作者信息

Sfyroera Georgia, Katragadda Madan, Morikis Dimitrios, Isaacs Stuart N, Lambris John D

机构信息

Department of Pathology and Laboratory Medicine,University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.

出版信息

J Immunol. 2005 Feb 15;174(4):2143-51. doi: 10.4049/jimmunol.174.4.2143.

DOI:10.4049/jimmunol.174.4.2143
PMID:15699145
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4138803/
Abstract

Regulation of complement activation by pathogens and the host are critical for survival. Using two highly related orthopoxvirus proteins, the vaccinia and variola (smallpox) virus complement control proteins, which differ by only 11 aa, but differ 1000-fold in their ability to regulate complement activation, we investigated the role of electrostatic potential in predicting functional activity. Electrostatic modeling of the two proteins predicted that altering the vaccinia virus protein to contain the amino acids present in the second short consensus repeat domain of the smallpox protein would result in a vaccinia virus protein with increased complement regulatory activity. Mutagenesis of the vaccinia virus protein confirmed that changing the electrostatic potential of specific regions of the molecule influences its activity and identifies critical residues that result in enhanced function as measured by binding to C3b, inhibition of the alternative pathway of complement activation, and cofactor activity. In addition, we also demonstrate that despite the enhanced activity of the variola virus protein, its cofactor activity in the factor I-mediated degradation of C3b does not result in the cleavage of the alpha' chain of C3b between residues 954-955. Our data have important implications in our understanding of how regulators of complement activation interact with complement, the regulation of the innate immune system, and the rational design of potent complement inhibitors that might be used as therapeutic agents.

摘要

病原体和宿主对补体激活的调节对于生存至关重要。我们利用两种高度相关的正痘病毒蛋白,即痘苗病毒和天花病毒补体控制蛋白,它们仅相差11个氨基酸,但在调节补体激活的能力上相差1000倍,研究了静电势在预测功能活性中的作用。对这两种蛋白的静电建模预测,将痘苗病毒蛋白改变为含有天花蛋白第二个短共有重复结构域中的氨基酸,会产生一种补体调节活性增强的痘苗病毒蛋白。痘苗病毒蛋白的诱变证实,改变分子特定区域的静电势会影响其活性,并确定了通过与C3b结合、抑制补体激活的替代途径和辅因子活性来衡量的导致功能增强的关键残基。此外,我们还证明,尽管天花病毒蛋白的活性增强,但其在因子I介导的C3b降解中的辅因子活性并不会导致C3b的α'链在954 - 955位残基之间的裂解。我们的数据对于我们理解补体激活调节因子如何与补体相互作用、先天免疫系统的调节以及可能用作治疗剂的有效补体抑制剂的合理设计具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4833/4138803/2b688bf874cf/nihms426834f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4833/4138803/0d0086582c20/nihms426834f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4833/4138803/deca9000848a/nihms426834f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4833/4138803/2516283b79b4/nihms426834f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4833/4138803/cb6a031d03a7/nihms426834f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4833/4138803/84bc6faad659/nihms426834f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4833/4138803/fab0edc06069/nihms426834f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4833/4138803/2b688bf874cf/nihms426834f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4833/4138803/0d0086582c20/nihms426834f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4833/4138803/deca9000848a/nihms426834f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4833/4138803/2516283b79b4/nihms426834f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4833/4138803/cb6a031d03a7/nihms426834f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4833/4138803/84bc6faad659/nihms426834f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4833/4138803/fab0edc06069/nihms426834f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4833/4138803/2b688bf874cf/nihms426834f7.jpg

相似文献

1
Electrostatic modeling predicts the activities of orthopoxvirus complement control proteins.静电建模可预测正痘病毒补体控制蛋白的活性。
J Immunol. 2005 Feb 15;174(4):2143-51. doi: 10.4049/jimmunol.174.4.2143.
2
Evolutionary history of orthopoxvirus proteins similar to human complement regulators.与人类补体调节因子相似的正痘病毒蛋白的进化史。
Gene. 2005 Aug 1;355:40-7. doi: 10.1016/j.gene.2005.05.008.
3
Species Specificity of Vaccinia Virus Complement Control Protein for the Bovine Classical Pathway Is Governed Primarily by Direct Interaction of Its Acidic Residues with Factor I.痘苗病毒补体控制蛋白对牛经典途径的物种特异性主要由其酸性残基与I因子的直接相互作用决定。
J Virol. 2017 Sep 12;91(19). doi: 10.1128/JVI.00668-17. Print 2017 Oct 1.
4
Interaction of vaccinia virus complement control protein with human complement proteins: factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway.牛痘病毒补体控制蛋白与人补体蛋白的相互作用:I 因子介导的 C3b 降解为 iC3b1 使替代补体途径失活。
J Immunol. 1998 Jun 1;160(11):5596-604.
5
Immunophysical properties and prediction of activities for vaccinia virus complement control protein and smallpox inhibitor of complement enzymes using molecular dynamics and electrostatics.利用分子动力学和静电学研究痘苗病毒补体控制蛋白和天花补体酶抑制剂的免疫物理性质及活性预测
Biophys J. 2006 May 1;90(9):3106-19. doi: 10.1529/biophysj.105.068130. Epub 2006 Feb 10.
6
Identification of hot spots in the variola virus complement inhibitor (SPICE) for human complement regulation.鉴定天花病毒补体抑制剂(SPICE)中用于人类补体调节的热点。
J Virol. 2008 Apr;82(7):3283-94. doi: 10.1128/JVI.01935-07. Epub 2008 Jan 23.
7
Variola virus immune evasion design: expression of a highly efficient inhibitor of human complement.天花病毒免疫逃逸设计:一种高效人类补体抑制剂的表达
Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8808-13. doi: 10.1073/pnas.112220499. Epub 2002 May 28.
8
Influence of electrostatics on the complement regulatory functions of Kaposica, the complement inhibitor of Kaposi's sarcoma-associated herpesvirus.静电力对 Kaposica(卡波西肉瘤相关疱疹病毒的补体抑制剂)补体调节功能的影响。
J Immunol. 2010 Feb 15;184(4):1956-67. doi: 10.4049/jimmunol.0903261. Epub 2010 Jan 20.
9
Identification of complement regulatory domains in vaccinia virus complement control protein.痘苗病毒补体控制蛋白中补体调节结构域的鉴定
J Virol. 2005 Oct;79(19):12382-93. doi: 10.1128/JVI.79.19.12382-12393.2005.
10
Conserved surface-exposed K/R-X-K/R motifs and net positive charge on poxvirus complement control proteins serve as putative heparin binding sites and contribute to inhibition of molecular interactions with human endothelial cells: a novel mechanism for evasion of host defense.痘病毒补体控制蛋白上保守的表面暴露K/R-X-K/R基序和净正电荷作为假定的肝素结合位点,有助于抑制与人类内皮细胞的分子相互作用:一种逃避宿主防御的新机制。
J Virol. 2000 Jun;74(12):5659-66. doi: 10.1128/jvi.74.12.5659-5666.2000.

引用本文的文献

1
Insight into mode-of-action and structural determinants of the compstatin family of clinical complement inhibitors.深入了解临床补体抑制剂 compstatin 家族的作用机制和结构决定因素。
Nat Commun. 2022 Sep 20;13(1):5519. doi: 10.1038/s41467-022-33003-7.
2
Complement component C3: A structural perspective and potential therapeutic implications.补体成分 C3:结构视角与潜在治疗意义。
Semin Immunol. 2022 Jan;59:101627. doi: 10.1016/j.smim.2022.101627. Epub 2022 Jun 25.
3
Potential participation of CTRP6, a complement regulator, in the pathology of age related macular degeneration.补体调节蛋白CTRP6可能参与年龄相关性黄斑变性的病理过程。
Jpn J Ophthalmol. 2022 May;66(3):326-334. doi: 10.1007/s10384-022-00913-4. Epub 2022 Apr 9.
4
Role of Electrostatic Hotspots in the Selectivity of Complement Control Proteins Toward Human and Bovine Complement Inhibition.静电热点在补体调节蛋白对人及牛补体抑制选择性中的作用
Front Mol Biosci. 2021 Mar 16;8:618068. doi: 10.3389/fmolb.2021.618068. eCollection 2021.
5
Incorporation of CD55 into the Zika Viral Envelope Contributes to Its Stability against Human Complement.CD55 的掺入有助于 Zika 病毒包膜抵抗人补体的稳定性。
Viruses. 2021 Mar 19;13(3):510. doi: 10.3390/v13030510.
6
Virus-Encoded Complement Regulators: Current Status.病毒编码的补体调节剂:现状。
Viruses. 2021 Jan 29;13(2):208. doi: 10.3390/v13020208.
7
Interference of the Zika Virus E-Protein With the Membrane Attack Complex of the Complement System.寨卡病毒 E 蛋白对补体系统膜攻击复合物的干扰。
Front Immunol. 2020 Oct 28;11:569549. doi: 10.3389/fimmu.2020.569549. eCollection 2020.
8
Species Specificity of Vaccinia Virus Complement Control Protein for the Bovine Classical Pathway Is Governed Primarily by Direct Interaction of Its Acidic Residues with Factor I.痘苗病毒补体控制蛋白对牛经典途径的物种特异性主要由其酸性残基与I因子的直接相互作用决定。
J Virol. 2017 Sep 12;91(19). doi: 10.1128/JVI.00668-17. Print 2017 Oct 1.
9
Complement Evasion Strategies of Viruses: An Overview.病毒的补体逃避策略:概述
Front Microbiol. 2017 Jun 16;8:1117. doi: 10.3389/fmicb.2017.01117. eCollection 2017.
10
Complement component C3 - The "Swiss Army Knife" of innate immunity and host defense.补体成分C3——固有免疫和宿主防御的“瑞士军刀”。
Immunol Rev. 2016 Nov;274(1):33-58. doi: 10.1111/imr.12500.

本文引用的文献

1
Kinetic analysis of the interactions between vaccinia virus complement control protein and human complement proteins C3b and C4b.痘苗病毒补体控制蛋白与人补体蛋白C3b和C4b相互作用的动力学分析。
J Virol. 2004 Sep;78(17):9446-57. doi: 10.1128/JVI.78.17.9446-9457.2004.
2
The Kaposi's sarcoma-associated herpesvirus complement control protein mimics human molecular mechanisms for inhibition of the complement system.卡波西肉瘤相关疱疹病毒补体控制蛋白模拟人类抑制补体系统的分子机制。
J Biol Chem. 2004 Oct 22;279(43):45093-101. doi: 10.1074/jbc.M407558200. Epub 2004 Aug 10.
3
DICHROWEB, an online server for protein secondary structure analyses from circular dichroism spectroscopic data.DICHROWEB,一个用于从圆二色光谱数据进行蛋白质二级结构分析的在线服务器。
Nucleic Acids Res. 2004 Jul 1;32(Web Server issue):W668-73. doi: 10.1093/nar/gkh371.
4
The electrostatic nature of C3d-complement receptor 2 association.C3d补体受体2结合的静电性质
J Immunol. 2004 Jun 15;172(12):7537-47. doi: 10.4049/jimmunol.172.12.7537.
5
Structure of vaccinia complement protein in complex with heparin and potential implications for complement regulation.痘苗补体蛋白与肝素复合物的结构及其对补体调节的潜在影响。
Proc Natl Acad Sci U S A. 2004 Jun 15;101(24):8924-9. doi: 10.1073/pnas.0400744101. Epub 2004 Jun 3.
6
The possibilities and pitfalls for anti-complement therapies in inflammatory diseases.抗炎性疾病中抗补体疗法的可能性与陷阱
Curr Drug Targets Inflamm Allergy. 2004 Mar;3(1):87-96. doi: 10.2174/1568010043483890.
7
The relevance of complement to virus biology.补体与病毒生物学的相关性。
Virology. 2004 Feb 20;319(2):176-84. doi: 10.1016/j.virol.2003.11.029.
8
Complement and complement regulatory proteins as potential molecular targets for vascular diseases.补体及补体调节蛋白作为血管疾病潜在的分子靶点。
Curr Pharm Des. 2004;10(2):203-11. doi: 10.2174/1381612043453441.
9
Herpes and pox viral complement control proteins: 'the mask of self'.疱疹病毒和痘病毒补体控制蛋白:“自身的面具”
Trends Immunol. 2003 Sep;24(9):500-7. doi: 10.1016/s1471-4906(03)00207-2.
10
Mapping of regions within the vaccinia virus complement control protein involved in dose-dependent binding to key complement components and heparin using surface plasmon resonance.利用表面等离子体共振技术对痘苗病毒补体控制蛋白中与关键补体成分和肝素进行剂量依赖性结合的区域进行图谱绘制。
Biochim Biophys Acta. 2003 Aug 21;1650(1-2):30-9. doi: 10.1016/s1570-9639(03)00189-4.